Pretty simple even for a layperson. The bavi arm is performing as expected but will not meet the assumptions tha it would beat the control arms to the extent expected. This I's due to control arm overachieving their expected results. Most likely due to there being new third line I/O drugs for control group to opt for after being told they are progressing